Clinical Trial Update: Usefulness of α-synuclein as a Marker for Early Diagnosis of Parkinson's Disease in Skin Biopsy.

View source ↗

Summary

A completed clinical trial evaluated skin biopsy α-synuclein as a marker for early diagnosis of Parkinson's disease with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Parkinsonian Disorders

Snippet

Sponsor: Universidad Autonoma de San Luis Potosí | Conditions: Parkinson Disease, Parkinsonian Disorders | Status: COMPLETED | Results posted: 2021-05-25